Filing Details
- Accession Number:
- 0001371285-20-000316
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-12-02 18:51:14
- Reporting Period:
- 2020-11-30
- Accepted Time:
- 2020-12-02 18:51:14
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1371285 | Trupanion Inc. | TRUP | Hospital & Medical Service Plans (6324) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1622728 | Asher Bearman | C/O Trupanion, Inc. 6100 4Th Avenue S, Suite 200 Seattle WA 98108 | Chief Strategy Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-11-30 | 2,345 | $101.02 | 3,787 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-11-30 | 1,573 | $98.72 | 2,214 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-11-30 | 12,655 | $4.77 | 14,869 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-11-30 | 12,655 | $100.53 | 2,214 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2020-11-30 | 12,655 | $0.00 | 12,655 | $4.77 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 67,162 | 2023-08-02 | No | 4 | M | Direct |
Footnotes
- The sales reported were effected in order to allow the reporting person to enter into a real estate purchase.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.00 to $101.065 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2).
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $98.665 to $99.15 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3).
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $99.84 to $101.48 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (4).
- This stock option grant is fully vested.
Billionaire Hedge Funds
